Melatonin Alleviates Acute Gouty Inflammation In Vivo and In Vitro

Abstract

The aim of this study was to identify the effects of melatonin on acute gouty inflammation and to investigate the underlying mechanisms. We found significantly lower serum melatonin levels in gout patients in the acute phase than in those in the remission phase or in normal individuals. The mRNA expression of melatonin receptor 2 (MT2) was also lower in gout patients than in normal individuals. To verify the in-vivo role of melatonin, a gouty arthritis model was established by intraarticular injection of monosodium urate (MSU, 1 mg) crystals into the paws of C57BL/6 mice. Joint inflammation in the mouse model was evaluated by measuring the thickness of the right paw/left paw, and the inflammation index was determined by examining infiltrating neutrophils with haematoxylin and eosin (H&E) staining. Melatonin was found to reduce both paw thickness and the inflammation index in the mouse model, and melatonin also reduced the mRNA levels of interleukin-1 beta (IL-1β), IL-6 and NLR family pyrin domain containing 3 (NLRP3) inflammasome. To mimic gouty inflammation in vitro, mouse peritoneal macrophages were stimulated with lipopolysaccharides (LPS) plus MSU. Melatonin was revealed to reduce IL-1β secretion by stimulated macrophages. The mRNA expression levels of IL-1β and IL-6 were also inhibited by melatonin. Western blot analysis showed that the expression of NLRP3, caspase-1 and pro-IL-1β was also inhibited by melatonin. In conclusion, our study demonstrated that melatonin alleviated gouty inflammation in vivo and in vitro, and the underlying mechanism may involve inhibiting the assembly of the NLRP3 inflammasome.

Keywords

melatonin / gout / NLRP3 inflammasome / monosodium urate

References

[1] DehlinM, JacobssonL, RoddyE, et al.. Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors. Nat Rev Rheumatol, 2020, 16(7): 380-390

[2] BevisM, BlagojevicBM, MallenC, et al.. Comorbidity clusters in people with gout: an observational cohort study with linked medical record review. Rheumatology (Oxford), 2018, 57: 1358-1363

[3] ChenB, LiH, OuG, et al.. Curcumin attenuates MSU crystal-induced inflammation by inhibiting the degradation of IκBα and blocking mitochondrial damage. Arthritis Res Ther, 2019, 21(1): 193-213

[4] ChungYH, KimHY, YoonBR, et al.. Suppression of Syk activation by resveratrol inhibits MSU crystal-induced inflammation in human monocytes. J Mol Med (Berl), 2019, 97(3): 369-383

[5] WahiK, KodarK, Mc ConnellMJ, et al.. MSU Crystals Enhance TDB-Mediated Inflammatory Macrophage IL-1β Secretion. Inflammation, 2019, 42(3): 1129-1136

[6] ClaustratB, LestonJ. Melatonin: Physiological effects in humans. Neurochirurgie, 2015, 61(2–3): 77-84

[7] SlominskiAT, ZmijewskiMA, SemakI, et al.. Melatonin, mitochondria, and the skin. Cell Mol Life Sci, 2017, 74(21): 3913-3925

[8] RahimI, DjerdjouriB, SayedRK, et al.. Melatonin adminisration to wild-type mice and nontreated NLRP3 mutant mice share similar inhibition of the inflammatory response during sepsis. J Pineal Res, 2017, 63(1): 12410-12422

[9] FaveroG, FranceschettiL, BonominiF, et al.. Melatonin as an anti-inflammatory agent modulating inflammasome activation. Int J Endocrinol, 2017, 2017: 1835195

[10] Wang J, Zhu XX, Liu L, et al. SIRT1 prevents hyperuricemia via the PGC-1a/PPARg-ABCG2 pathway. Endocrine,2016(53):443–452

[11] BhattacharyaS, PatelKK, DehariD, et al.. Melatonin and its ubiquitous anticancer effects. Mol Cell Biochem, 2019, 462(1–2): 133-155

[12] CardinaliDP. Melatonin: clinical perspectives in neurodegeneration. Front Endocrinol (Lausanne), 2019, 10: 480-490

[13] NajafiM, ShiraziA, MotevaseliE, et al.. The melatonin immunomodulatory actions in radiotherapy. Biophys Rev, 2017, 9(2): 139-148

[14] ReiterRJ, TanDX, Rosales-CorralS, et al.. Melatonin mitigates mitochondrial meltdown: interactions with Sirt3. Int J Mol Sci, 2018, 19(8): 2439-2450

[15] GursoyAY, KiseliM, CaglarGS. Melatonin in aging women. Climacteric, 2015, 18(6): 790-796

[16] CardinaliDP. Melatonin: clinical perspectives in neurodegeneration. Front Endocrinol (Lausanne), 2019, 10: 480-489

[17] HardelandR. Aging, melatonin, and the pro- and anti-inflammatory networks. Int J Mol Sci, 2019, 20(5): 1223-1233

[18] YuGM, KubotaH, OkitaM, et al.. The anti-inflammatory and antioxidant effects of melatonin on LPS-stimulated bovine mammary epithelial cells. PLoS One, 2017, 12(5): 112-130

[19] FarezMF, CalandriIL, CorrealeJ, et al.. Anti-inflammatory effects of melatonin in multiple sclerosis. Bioessays, 2016, 38(10): 1016-1026

[20] SongZ, HumarB, GuptaA, et al.. Exogenous melatonin protects small-for-size liver grafts by promoting monocyte infiltration and releases interleukin-6. J Pineal Res, 2018, 65(1): 12486-12510

[21] LiuZ, GanL, XuY, et al.. Melatonin alleviates inflammasome-induced pyroptosis through inhibiting NF-κB/GSDMD signal in mice adipose tissue. J Pineal Res, 2017, 63(1): 10-30

[22] ZhangY, LiX, GrailerJJ, et al.. Melatonin alleviates acute lung injury through inhibiting the NLRP3 inflammasome. J Pineal Res, 2016, 60(4): 405-414

[23] CaoS, ShresthaS, LiJ, et al.. Melatonin-mediated mitophagy protects against early brain injury after subarachnoid hemorrhage through inhibition of NLRP3 inflammasome activation. Sci Rep, 2017, 7(1): 2417-2427

[24] CaoZ, FangY, LuY, et al.. Melatonin alleviates cadmium-induced liver injury by inhibiting the TXNIP-NLRP3 inflammasome. J Pineal Res, 2017, 62(3): 10-23

[25] ZhangJ, LuX, LiuM, et al.. Melatonin inhibits inflammasome-associated activation of endothelium and macrophages attenuating pulmonary arterial hypertension. Cardiovasc Res, 2019, 10: 312-328

[26] HeY, HaraH, NúñezG. Mechanism and regulation of NLRP3 inflammasome activation. Trends Biochem Sci, 2016, 41(12): 1012-1021

[27] HoseiniZ, SepahvandF, RashidiB, et al.. NLRP3 inflammasome: its regulation and involvement in atherosclerosis. J Cell Physiol, 2018, 233(3): 2116-2132

[28] ZhongZ, LiangS, Sanchez-LopezE, et al.. New mitochondrial DNA synthesis enables NLRP3 inflammasome activation. Nature, 2018, 560(7717): 198-203

[29] MartinWJ, WaltonM, HarperJ. Resident macrophages initiating and driving inflammation in a monosodium urate monohydrate crystal-induced murine peritoneal model of acute gout. Arthritis Rheum, 2009, 60(1): 281-289

[30] Palazón-RiquelmeP, WorboysJD, GreenJ, et al.. USP7 and USP47 deubiquitinases regulate NLRP3 inflammasome activation. EMBO Rep, 2018, 19(10): 447-486